Patents by Inventor Lan Zhang

Lan Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11943285
    Abstract: Methods and systems for metering computing resources in cloud computing environments are disclosed. A method includes: executing, by a computing device, computing tasks on computing resources; determining, by the computing device, an amount of time and an amount of power used in the executing the computing tasks on the computing resources; determining, by the computing device, a number of standard units consumed by the computing tasks based on the determined amount of time and the determined amount of power; and metering, by the computing device, the computing resources based on the determined number of standard units consumed by the computing tasks.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: March 26, 2024
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Li Xia, Lan Luo, Jian Dong Yin, Jian Zhang, Li Long Chen
  • Patent number: 11943373
    Abstract: An identity certificate may be issued to a blockchain node. The issuance may include issuing a first identity certificate to a first terminal and receiving a second identity certificate issuance request that is from the first terminal. A second identity certificate may be issued to the first terminal, and a third identity certificate issuance request is received from the second terminal. A third identity certificate is issued to the second terminal, so that the second terminal forwards the third identity certificate to the third terminal.
    Type: Grant
    Filed: June 2, 2021
    Date of Patent: March 26, 2024
    Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED
    Inventors: Mao Cai Li, Zong You Wang, Kai Ban Zhou, Chang Qing Yang, Hu Lan, Li Kong, Jin Song Zhang, Yi Fang Shi, Geng Liang Zhu, Qu Cheng Liu, Qiu Ping Chen
  • Publication number: 20240097056
    Abstract: A back passivation crystalline silicon solar cell includes an Ag gate finger electrode, a SiNx passivation antireflection layer, an N+ layer, P-type silicon, a back passivation layer, and an Al gate finger electrode, connected sequentially from top to bottom. The Ag gate finger electrode sequentially penetrates through the SiNx passivation antireflection layer and the N+ layer and is connected to the P-type silicon by means of an N++ layer. The Al gate finger electrode penetrates through the back passivation layer and is connected to the P-type silicon by a P+ layer. The back passivation layer is a passivation antireflection laminated structure that includes a SiO2 passivation layer, an AlOx passivation layer, a SiNx antireflection layer, and a SiOxNy antireflection layer, sequentially provided from top to bottom. The solar cell has high carrier selectivity, high temperature stability, excellent interface passivation effect and PID resistance, high conversion efficiency and high stability.
    Type: Application
    Filed: August 13, 2020
    Publication date: March 21, 2024
    Applicants: Tongwei Solar (Chengdu) Co., Ltd., Tongwie Solar (Meishan) Co., Ltd.
    Inventors: Peng ZHANG, Kun CHEN, Lan WANG, Zhiwei YIN
  • Patent number: 11927865
    Abstract: An electrochromic device with side-by-side structure including a common electrode unit, at least one color-changing unit and an electrolyte layer is provided. The common electrode unit includes an electrode layer and an electrode protection layer disposed on the electrode layer. The color-changing unit includes a transparent conductive layer and a color-changing layer disposed on the transparent conductive layer. The common electrode unit and each color-changing unit are arranged on the same plane with an insulating region between two adjacent units. The electrolyte layer covers and connects the electrode protection layer of the common electrode unit and the color-changing layer of each color-changing unit.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: March 12, 2024
    Assignee: WUYI UNIVERSITY
    Inventors: Xiufeng Tang, Guoxin Chen, Yongxian Li, Zhixin Li, Zhaopeng Mo, Zhijun Ou, Tengcheng Huang, Lan Su, Zehui Zhang, Jianyi Luo
  • Patent number: 11911453
    Abstract: The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The vaccine can be formulated in a lipid nanoparticle.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: February 27, 2024
    Assignee: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Kapil Bahl, Amy Espeseth, Andrew J. Bett, Pedro Cejas, Lan Zhang, Christine Shaw
  • Patent number: 11871772
    Abstract: The present disclosure generally provides compounds that antagonize certain T2R taste receptors, including related uses, methods, and compositions for the reduction of bitter taste and/or the enhancement of sweet taste. In certain aspects, the disclosure provides flavored articles or flavored compositions comprising such compounds, as well as uses of such compounds to reduce the bitter taste and/or enhance the sweet taste of such flavored articles or flavored compositions.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: January 16, 2024
    Assignee: Firmenich Incorporated
    Inventors: Joseph R. Fotsing, Andrew Patron, Guy Servant, Lan Zhang, Mark Williams, Qing Chen, Kenneth Simone, Vincent Darmohusodo, Chad Priest, Melissa S. Wong, Thomas Brady
  • Patent number: 11842143
    Abstract: A method, computer system, and a computer program product is provided for generating a detailed thumbnail and/or preview of a content. In one embodiment the technique comprises analyzing data obtained from a content and classifying it according to a plurality of specific types. A plurality of key information may be then extracted from the data according to the classification. A plurality of key-values are correlated to the plurality of key information so as to provide a plurality of key-value pairs. These pairs are consolidated accordingly to generate a thumbnail and/or a preview that at least renders the key information provided by the consolidated key-value pairs as a rendering.
    Type: Grant
    Filed: August 30, 2022
    Date of Patent: December 12, 2023
    Assignee: International Business Machines Corporation
    Inventors: Dong Rui Li, Zai Ming Lao, Ye Chen, Xue Lan Zhang, Xue Xu
  • Publication number: 20230310576
    Abstract: The disclosure relates to broad spectrum influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: November 14, 2022
    Publication date: October 5, 2023
    Applicant: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Eric Yi-Chun Huang, Kerim Babaoglu, Jessica Anne Flynn, Lan Zhang, David Nickle
  • Patent number: 11752206
    Abstract: Herpes simplex virus (HSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: September 12, 2023
    Assignee: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Andrew J. Bett, Danilo R. Casimiro, Dai Wang, Lan Zhang
  • Publication number: 20230225684
    Abstract: In an embodiment, a method (100) is described. The method comprises receiving (102) data corresponding to a plurality of radiographic imaging slices of a body. The method further comprises determining (104) a position of a needle inserted in the body. The determination is based on combining information from at least one of the radiographic imaging slices comprising an indication of a first portion of the needle outside the body and at least one other of the radiographic imaging slices comprising an indication of a second portion of the needle inside the body. A combined needle region is generated by merging data corresponding to a position of the first portion of the needle outside the body with data corresponding to a position of the second portion of the needle inside the body.
    Type: Application
    Filed: June 21, 2021
    Publication date: July 20, 2023
    Inventors: YANHUA SHEN, LING FU, YUE MA, DI ZHANG, LAN ZHANG, YUE ZHENG
  • Publication number: 20230212269
    Abstract: The present invention relates to monoclonal antibodies which have high anti-RSV neutralizing titers. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. The invention yet further provides for diagnostic, prophylactic and therapeutic methods employing the antibodies and nucleic acids of the invention, particularly as a passive immunotherapy agent in infants and the elderly.
    Type: Application
    Filed: December 13, 2022
    Publication date: July 6, 2023
    Applicant: Merck Sharp & Dohme LLC
    Inventors: Kalpit A. Vora, Kara S. Cox, Aimin Tang, Zhifeng Chen, Daniel DiStefano, Lan Zhang, Hua-Poo Su
  • Publication number: 20230141153
    Abstract: The disclosure relates to stable RSV F proteins and immunogenic compositions containing the same, as well as methods of using the immunogenic compositions and compositions comprising the RSV F proteins.
    Type: Application
    Filed: December 20, 2022
    Publication date: May 11, 2023
    Applicant: Merck Sharp & Dohme LLC
    Inventors: Lan Zhang, Arthur Fridman, Eberhard Durr, Andrew Bett
  • Patent number: 11633725
    Abstract: Here disclosed is a composite catalyst for methane cracking and a method of producing the composite catalyst.
    Type: Grant
    Filed: April 30, 2021
    Date of Patent: April 25, 2023
    Assignee: Nanyang Technological University
    Inventors: Lan Zhang, Siew Hwa Chan, Bin Miao
  • Patent number: 11576961
    Abstract: The disclosure relates to broad spectrum influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccine. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: February 14, 2023
    Assignee: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Eric Yi-Chun Huang, Kerim Babaoglu, Jessica Anne Flynn, Lan Zhang, David Nickle
  • Patent number: 11566065
    Abstract: The present invention relates to monoclonal antibodies which have high anti-RSV neutralizing titers. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. The invention yet further provides for diagnostic, prophylactic and therapeutic methods employing the antibodies and nucleic acids of the invention, particularly as a passive immunotherapy agent in infants and the elderly.
    Type: Grant
    Filed: December 8, 2020
    Date of Patent: January 31, 2023
    Assignee: MERCK SHARP & DOHME LLC
    Inventors: Kalpit A. Vora, Kara S. Cox, Aimin Tang, Zhifeng Chen, Daniel DiStefano, Lan Zhang, Hua-Poo Su
  • Patent number: 11566051
    Abstract: The disclosure relates to stable RSV F proteins and immunogenic compositions containing the same, as well as methods of using the immunogenic compositions and compositions comprising the RSV F proteins.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: January 31, 2023
    Assignee: Merck Sharp & Dohme LLC
    Inventors: Lan Zhang, Arthur Fridman, Eberhard Durr, Andrew Bett
  • Patent number: 11537947
    Abstract: In one example, the present disclosure describes a device, computer-readable medium, and method for automatically learning and facilitating interaction routines involving at least one human participant. In one example, a method includes learning an interaction routine conducted between a human user and a second party, wherein the interaction routine comprises a series of prompts and responses designed to identify and deliver desired information, storing a template of the interaction routine based on the learning, wherein the template includes at least a portion of the series of prompts and responses, detecting, in the course of a new instance of the interaction routine, at least one prompt from the second party that requests a response from the human user, and using the template to provide a response to the prompt so that involvement of the human user in the new instance of the interaction routine is minimized.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: December 27, 2022
    Assignee: AT&T Intellectual Property I, L.P.
    Inventors: Harry Blanchard, Lan Zhang, Gregory Pulz
  • Publication number: 20220378892
    Abstract: The present invention relates to methods for the recombinant expression of chlamydia major outer membrane protein (MOMP) comprising transforming a population of E. coli host cells with an expression vector comprising a nucleic acid molecule that encodes chlamydia MOMP and encodes a leader sequence for targeting the MOMP to the outer membrane of the cell, wherein the nucleic acid molecule is operatively linked to a promoter. The method of the invention allows expression of MOMP in the outer membrane of the cell, which leads to protein folding that is more like native MOMP relative to a MOMP protein that is expressed intracellularly. Also provided by the invention are uses of the recombinant MOMP in pharmaceutical compositions and methods for the treatment and/or prophylaxis of chlamydia infection and/or the effects thereof.
    Type: Application
    Filed: July 1, 2022
    Publication date: December 1, 2022
    Applicant: Merck Sharp & Dohme LLC
    Inventors: Lan Zhang, Zhiyun Wen, Craig T. Przysiecki, Puneet Khandelwal, Ping Qiu
  • Publication number: 20220363760
    Abstract: The present disclosure provides methods of identifying a subject suitable for an immunooncology (I-O) therapy comprising measuring the expression of one or more genes of a pantumor inflammation gene panel. In some aspects, the method further comprises administering an I-O therapy to the subject. In some aspects, the I-O therapy comprises administering an anti-PD-1 antibody or antigen-binding portion thereof or an anti-PD-L1 antibody or antigen-binding portion thereof to the subject.
    Type: Application
    Filed: May 29, 2020
    Publication date: November 17, 2022
    Applicant: Bristol-Myers Squibb Company
    Inventors: Peter M. SZABO, Lan ZHANG, Keyur H. DESAI, Neeraj ADYA, Zhenhao QI, Kim ZERBA, Scott Adams ELY, Saumya PANT, George A. GREEN
  • Publication number: 20220330591
    Abstract: The present disclosure generally provides compounds that antagonize certain T2R taste receptors, including related uses, methods, and compositions for the reduction of bitter taste and/or the enhancement of sweet taste. In certain aspects, the disclosure provides flavored articles or flavored compositions comprising such compounds, as well as uses of such compounds to reduce the bitter taste and/or enhance the sweet taste of such flavored articles or flavored compositions.
    Type: Application
    Filed: August 8, 2019
    Publication date: October 20, 2022
    Applicant: Firmenich Incorporated
    Inventors: Joseph R. Fotsing, Andrew Patron, Guy Servant, Lan Zhang, Mark Williams, Qing Chen, Kenneth Simone, Vincent Darmohusodo, Chad Priest, Melissa S. Wong, Thomas Brady